WebApr 24, 2024 · In this pivotal, randomised, triple-blind, sham-controlled trial, done in 19 stroke rehabilitation services in the UK and the USA, participants with moderate-to-severe arm weakness, at least 9 months after ischaemic stroke, were randomly assigned (1:1) to either rehabilitation paired with active vagus nerve stimulation (VNS group) or … WebDec 10, 2024 · A two-dose regimen of BNT162b2 (30 μg per dose, given 21 days apart) was found to be safe and 95% effective against Covid-19. The vaccine met both primary efficacy end points, with more than a 99 ...
Adjunctive metformin for antipsychotic-induced …
WebAug 9, 2024 · Official Title: Efficacy and Safety Study of Novel Spectacle Lens Designs to Control of Myopia. Actual Study Start Date : July 16, 2024. Actual Primary Completion … WebBackground: We report long-term efficacy and cardiac safety outcomes in patients with HER2-positive early breast cancer treated with neoadjuvant pertuzumab plus trastuzumab … cotton drill boilersuit
Control of Myopia Using Novel Spectacle Lens Designs …
WebNov 5, 2024 · Kumar:Carsgen: Other, Research Funding; Kite Pharma: Consultancy, Research Funding; Oncopeptides: Consultancy, Other: Independent Review Committee; IRC member; Celgene/BMS: Other: Research funding for clinical trials to the institution, Consulting/Advisory Board participation with no personal payments; Genentech/Roche: … WebMar 30, 2016 · This systematic review examines adjunctive metformin therapy for the treatment of antipsychotic-induced hyperprolactinemia. A computerized search of … WebA study of Lanabecestat (LY3314814) in participants with mild Alzheimer\u0027s disease dementia Pharma Intelligence. This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. magazine spread